Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Insmed Inc

INSM
Current price
26.97 USD +0.47 USD (+1.77%)
Last closed 26.52 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 794 004 224 USD
Yield for 12 month +35.60 %
Week
Month
Year
INSM
21.11.2021 - 28.11.2021

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis, cystic fibrosis, and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey. Address: 700 US Highway 202/206, Bridgewater, NJ, United States, 08807

Analytics

WallStreet Target Price

41.42 USD

P/E ratio

Dividend Yield

1.4 %

Current Year

+245 358 000 USD

Last Year

+188 461 000 USD

Current Quarter

+79 072 000 USD

Last Quarter

+77 229 000 USD

Current Year

+190 232 000 USD

Last Year

+144 309 000 USD

Current Quarter

+62 366 000 USD

Last Quarter

+60 635 000 USD

Key Figures INSM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -663 046 976 USD
Operating Margin TTM -175.37 %
PE Ratio
Return On Assets TTM -36.19 %
PEG Ratio
Return On Equity TTM -1453.41 %
Wall Street Target Price 41.42 USD
Revenue TTM 280 815 008 USD
Book Value -2.02 USD
Revenue Per Share TTM 2.04 USD
Dividend Share
Quarterly Revenue Growth YOY 16.7 %
Dividend Yield 1.4 %
Gross Profit TTM 190 232 000 USD
Earnings Share -5.29 USD
Diluted Eps TTM -5.29 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -257.69 %

Dividend Analytics INSM

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History INSM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 1.4 %
Last Split Factor 1:10
Payout Ratio
Last Split Date 03.03.2011
Dividend Date

Stock Valuation INSM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 14.965
Price Sales TTM 13.5107
Enterprise Value EBITDA -6.5734
Price Book MRQ 30.4136

Financials INSM

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators INSM

For 52 weeks

16.04 USD 27.59 USD
50 Day MA 24.79 USD
Shares Short Prior Month 15 444 224
200 Day MA 21.4 USD
Short Ratio 10.72
Shares Short 14 165 978
Short Percent 10.05 %